Bruce Shutan

2 weeks ago | benefitnews.com | Bruce Shutan

Class-action lawsuits alleging breaches in fiduciary responsibilities involving group health plans and pharmacy benefits at several blue-chip companies continue to make headlines as they command the full attention of benefit advisers. Filed amid a federal crackdown on price transparency, the common denominator is inflated prescription drug prices. The latest involves JPMorgan, which also was sued over 401(k) forfeited funds and plan assets invested in an in-house stable value fund.

2 weeks ago | dig-in.com | Bruce Shutan

When Chris Wolpert founded Group Benefit Solutions in 2016, a certain inspirational quote about growing business always stuck with him: Sales guys have business cards, but experts have books. "I was in my early 30s at the time and looking for little credit credibility," he sheepishly confessed. "With a background in writing and storytelling, I wanted to leverage that skill and thought writing a book would be a good way to do that."  It didn't take long for the benefits adviser to be published.

2 weeks ago | benefitnews.com | Bruce Shutan

When Chris Wolpert founded Group Benefit Solutions in 2016, a certain inspirational quote about growing business always stuck with him: Sales guys have business cards, but experts have books. "I was in my early 30s at the time and looking for little credit credibility," he sheepishly confessed. "With a background in writing and storytelling, I wanted to leverage that skill and thought writing a book would be a good way to do that."  It didn't take long for the benefits adviser to be published.

2 weeks ago | benefitnews.com | Bruce Shutan

Part 5 in a series about MSK conditions and how advisers are changing their approach to treatment with new benefit solutions. Amid the frantic search to end his MSK pain, Voluntary Disruption founder Eric Silverman leaned into his corporate mission to improve employee engagement. He knows enough not to randomly pick a doctor or surgeon and caution others against doing that.

3 weeks ago | benefitnews.com | Bruce Shutan

Part 4 in an ongoing series about MSK conditions and how advisers are changing their approach to treatment with new benefit solutions. Benefit advisers know all too well how musculoskeletal (MSK) conditions can drive up claim costs. They secured the No. 4 spot among 19 of the highest stop-loss claim reimbursements in a 2024 report by Sun Life.   That point hit particularly close to home for several industry leaders who learned valuable lessons from their respective MSK challenges.